Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Sun Pharmaceutical Industries Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

25 Apr 2015 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - SUN PHARMACEUTICALS INDUSTRIES LTD (SUNPHARMA-IN)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

27 Apr 2015 Thomson Reuters Stock Report 11 $25.00

Sun Pharmaceutical Industries Limited (SUNPHARMA) - Financial and Strategic SWOT Analysis Review

Sun Pharmaceutical Industries Limited (SUNPHARMA) - Financial and Strategic SWOT Analysis Review Summary Sun Pharmaceutical I...

08 Apr 2015 GlobalData 61 $125.00

Wright Investors Service Comprehensive Report for Sun Pharmaceuticals Industries Ltd

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

08 Apr 2015 Wright Reports 55 $75.00

Company Snapshot - Sun Pharmaceuticals Industries

A director at Sun Pharmaceuticals Industries sold 4,600 shares at 1,012.565INR and the significance rating of the trade was 6...

10 Mar 2015 Directors Deals Ltd. 1 $12.00

MOSL: SUN PHARMA (Buy) - Halol concerns allayed – reiterate as top pick

SUN PHARMA: Halol concerns allayed – reiterate as top pick; Ranbaxy merger completion imminent, synergies to unlock value (S...

05 Mar 2015 Motilal Oswal Securities Ltd. 10 $104.00

Sun Pharma - Q3FY15 Result Update - "ACCUMULATE" - KRChoksey Research - “Weak quarter”

“Weak quarter” Result highlights Sun Pharma’s Q3FY15 results were below our estimates on account of temporary supply constrai...

16 Feb 2015 Kisan Ratilal Choksey Shares and Securities Private Limited 7 $69.00

MOSL: SUN PHARMA (Buy) - 3Q blip due to supply constraints, expects rebound from 4Q itself

SUN PHARMA 3QFY15: 3Q blip due to supply constraints, expects rebound from 4Q itself (SUNP IN, Mkt Cap USD32b, CMP INR940, T...

16 Feb 2015 Motilal Oswal Securities Ltd. 14 $150.00

Sun Pharmaceuticals (SUNP) - Qtr. Update - Dated - February 14, 2015

Sun Pharma (Bloomberg: SUNP IN, BUY, TP – Rs 1,060, 13% upside from CMP of Rs 939) SUNP reported Q3 PAT (-7% YoY) was 13%/...

16 Feb 2015 Axis Capital Limited 7 $69.00

Sun Pharmaceutical Industries Ltd. | Q3FY15 Result Update | A Muted quarter; however, outlook remains optimistic | Maintain HOLD rating with revise PT to Rs921 (from Rs831)

Sun Pharmaceutical Industries Ltd. | Q3FY15 Result Update A Muted quarter; however, outlook remains optimistic | Maintain HO...

15 Feb 2015 IndiaNivesh Securities Pvt Ltd 5 $46.00